Cargando…

Target product profile for readers of rapid diagnostic tests

While equipment-free visual interpretation is a benefit of lateral-flow assays, automating the reading of rapid diagnostic tests promotes proper test performance, interpretation and reporting of the results. We have created a target product profile that describes the minimal and optimal characterist...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Wallace, Kadam, Rigveda, Moussy, Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140691/
https://www.ncbi.nlm.nih.gov/pubmed/37131947
http://dx.doi.org/10.2471/BLT.23.289728
_version_ 1785033216294387712
author White, Wallace
Kadam, Rigveda
Moussy, Francis
author_facet White, Wallace
Kadam, Rigveda
Moussy, Francis
author_sort White, Wallace
collection PubMed
description While equipment-free visual interpretation is a benefit of lateral-flow assays, automating the reading of rapid diagnostic tests promotes proper test performance, interpretation and reporting of the results. We have created a target product profile that describes the minimal and optimal characteristics of various rapid diagnostic test readers. The product profile is intended to promote the development of effective, useful, sustainable rapid diagnostic test readers in support of health programmes worldwide. These readers may be custom hardware or software-only running on a general-purpose mobile device, for professional or lay use, and for medical or non-medical purposes. During the development of the product profile, the World Health Organization and FIND convened a development group of 40 leading scientists, experts, public health officials and regulators. We held a public consultation to which 27 individuals or organizations responded. The product profile calls for rapid diagnostic test readers that at minimum should: (i) interpret colorimetric tests with at least 95% agreement with expert visual interpretation; and (ii) automatically report results and associated data for the health programme. Optimally, readers should: (i) provide at least 98% agreement; (ii) operate with multiple models of rapid diagnostic tests; (iii) assist the user in performing each rapid diagnostic test according to the test instructions; and (iv) offer multiple configurations, operating modes and languages to suit the needs of diverse users, settings and health programmes.
format Online
Article
Text
id pubmed-10140691
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher World Health Organization
record_format MEDLINE/PubMed
spelling pubmed-101406912023-05-01 Target product profile for readers of rapid diagnostic tests White, Wallace Kadam, Rigveda Moussy, Francis Bull World Health Organ Policy & Practice While equipment-free visual interpretation is a benefit of lateral-flow assays, automating the reading of rapid diagnostic tests promotes proper test performance, interpretation and reporting of the results. We have created a target product profile that describes the minimal and optimal characteristics of various rapid diagnostic test readers. The product profile is intended to promote the development of effective, useful, sustainable rapid diagnostic test readers in support of health programmes worldwide. These readers may be custom hardware or software-only running on a general-purpose mobile device, for professional or lay use, and for medical or non-medical purposes. During the development of the product profile, the World Health Organization and FIND convened a development group of 40 leading scientists, experts, public health officials and regulators. We held a public consultation to which 27 individuals or organizations responded. The product profile calls for rapid diagnostic test readers that at minimum should: (i) interpret colorimetric tests with at least 95% agreement with expert visual interpretation; and (ii) automatically report results and associated data for the health programme. Optimally, readers should: (i) provide at least 98% agreement; (ii) operate with multiple models of rapid diagnostic tests; (iii) assist the user in performing each rapid diagnostic test according to the test instructions; and (iv) offer multiple configurations, operating modes and languages to suit the needs of diverse users, settings and health programmes. World Health Organization 2023-05-01 2023-03-14 /pmc/articles/PMC10140691/ /pubmed/37131947 http://dx.doi.org/10.2471/BLT.23.289728 Text en (c) 2023 The authors; licensee World Health Organization. https://creativecommons.org/licenses/by/3.0/igo/This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode (https://creativecommons.org/licenses/by/3.0/igo/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.
spellingShingle Policy & Practice
White, Wallace
Kadam, Rigveda
Moussy, Francis
Target product profile for readers of rapid diagnostic tests
title Target product profile for readers of rapid diagnostic tests
title_full Target product profile for readers of rapid diagnostic tests
title_fullStr Target product profile for readers of rapid diagnostic tests
title_full_unstemmed Target product profile for readers of rapid diagnostic tests
title_short Target product profile for readers of rapid diagnostic tests
title_sort target product profile for readers of rapid diagnostic tests
topic Policy & Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140691/
https://www.ncbi.nlm.nih.gov/pubmed/37131947
http://dx.doi.org/10.2471/BLT.23.289728
work_keys_str_mv AT whitewallace targetproductprofileforreadersofrapiddiagnostictests
AT kadamrigveda targetproductprofileforreadersofrapiddiagnostictests
AT moussyfrancis targetproductprofileforreadersofrapiddiagnostictests